Suvoda's Agentic RTSM Revolutionizes Clinical Trials with Significant Time Savings

Revolutionizing Clinical Trials with Suvoda's Agentic RTSM

In the world of clinical research, the journey from contract signing to trial initiation has traditionally been marred by delays, often extending over several months. This lengthy process not only burdens the sponsors aiming to deliver vital therapies to patients but also poses significant challenges in the overall efficiency of clinical trials. Enter Suvoda, a global leader in clinical trial technology, which has introduced an innovative solution: Agentic RTSM. This cutting-edge randomization and trial supply management system promises to reduce start-up timelines by up to 80%.

What is Agentic RTSM?

Suvoda's Agentic RTSM represents the next step in the evolution of their Interactive Response Technology (IRT). This state-of-the-art system harnesses the power of artificial intelligence (AI) to expedite various phases of clinical trial preparations, ensuring a smoother path to patient enrollment. By leveraging AI capabilities, Agentic RTSM allows trials to move from initiation to User Acceptance Testing (UAT) in just two weeks—a stark contrast to the traditional timelines.

Key Benefits

Agentic RTSM is not just a technological advancement; it is part of a broader AI strategy designed to enhance the clinical trial experience for sponsors and study teams. Here are the three primary benefits it offers:
1. Accelerated Study Preparation: By shortening the time from trial initiation to UAT, Agentic RTSM facilitates faster access to essential information and streamlines project timelines significantly.
2. Improved User Experience: With this system in place, sponsors and study centers enjoy a more efficient workflow, resulting in reduced administrative burdens and quicker access to crucial trial data.
3. Enhanced Insights: The platform also offers data-driven insights, empowering study teams with a clearer understanding of trial statuses and supporting better decision-making processes.

Revolutionizing Study Development

At its core, Agentic RTSM utilizes multiple AI agents that work concurrently to speed up different aspects of trial development—from software configuration and customization to software testing and modifications. By capitalizing on Suvoda's proprietary architecture, the system employs virtual partitioning and low-code/no-code tools to accelerate agent configuration. This unique approach allows for rapid setups and modifications, based on comprehensive data derived from previous complex trials.

Jagath Wanninayake, CEO of Suvoda, emphasizes the urgency and complexity of modern clinical trials: "Our clients shouldn’t have to deal with technologies that slow them down. By implementing agent-based clinical trial management, we enable sponsors to start patient recruitment earlier and support study teams to focus on what truly matters."

The Future of Clinical Trials

Suvoda is currently collaborating with a select group of pioneering users to deploy Agentic RTSM capabilities, setting the stage for a broader implementation and operational foundation. Alongside this, Suvoda is continually enhancing Sofia, its AI assistant, to facilitate monitoring, provide alerts, and streamline actions with necessary safeguards to support trial processes efficiently.

Looking to the future, Suvoda aims to expand agent-based models to eCOA (electronic Clinical Outcome Assessment) and financial service products, reinforcing speed and consistency across participant journeys, questionnaires, and patient payment processes.

As E.K. Koh, the product director at Suvoda, succinctly puts it, "Agentic RTSM is one of the first steps in a broader vision for AI in clinical trials. Speed, quality, and experience can coexist harmoniously in this realm."

Ultimately, the core mission of Suvoda’s RTSM initiative is to prioritize the needs of those it ultimately serves: sponsors testing new treatments, clinical centers conducting studies, and patients awaiting critical therapies. A quicker initiation phase is not merely an operational metric; it's a crucial step in getting life-saving medications into the hands of those who need them most.

About Suvoda

Founded to be at the forefront of clinical trial technology, Suvoda offers a leading real-time software platform that equips sponsors and Contract Research Organizations (CROs) with the confidence to make informed decisions while allowing centers and patients to act with peace of mind and control. Their interconnected, action-oriented software solutions and industry-leading support ensure that even in the most urgent times, transformative studies continue to progress. With headquarters near Philadelphia and offices in Portland, Oregon, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan, Suvoda maintains a customer satisfaction rate that consistently surpasses industry averages. Recently, Suvoda merged with Greenphire, a prominent provider of financial management tools and patient support for clinical trials. To learn more, visit suvoda.com and follow Suvoda on LinkedIn.